FDA diabetes drug warning
The agency has released a new warning about the drug Byetta.
U.S. (WiredPRNews.com) – The U.S. Food and Drug Administration (FDA) has released a warning about the diabetes medication Byetta. As reported by HealthDay News, the drug exenatide, which is marketed as Byetta, has been linked to kidney problems, including renal failure.
Dr. Amy Egan, of the Division of Metabolism and Endocrinology Products at the FDA’s Center for Drug Evaluation and Research, is quoted in the report as stating of the Type II diabetes medication, “Health-care professionals and patients taking Byetta should pay close attention to any signs or symptoms of kidney problems… Patients also should be aware that problems with kidney function could lead to changes in urine color, frequency of urination or the amount of urine, unexplained swelling of the hands or feet, fatigue, changes in appetite or digestion, or dull ache in the mid- to lower back.”
WiredPRNews.com – The latest in Medical News
Tags: Byetta, diabetes drug, Endocrinology, exenatide, FDA, kidney problems, renal failure, warningOnline Medical News News Press Release Distribution - WiredPRNews.com
- Soprano Laser Hair Removal Now More Effective then IPL
- High Dose Rate Electronic Radiation Skin Cancer Treatment Now Available in US
- Sandusky Accusers Get Foundation’s Help
- Houston Pilates instructor now equipped to help post-operative breast cancer survivors
- Compounding Pharmacy Offers Solution for Mibolerone (Cheque Drops) Shortage
- Physical Therapy Documentation Software Maker Shares iOS5 Tips
- PD Patient Advises, “Key to staying active — stay active!”
- Missing Teeth No Longer Stand in the Way of a Beautiful Smile
- Presidential Candidate Brain Freeze Common in Peri-Menopausal Women
- Cate School Launches Long-Term Study to Monitor Adolescent and Young Adult Hearts
